where they received both an oral antibiotic and a topical antibiotic cream for one week, or to a control group. The control group for this trial received female antibiotic treatment only and no ...

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. The latest program to be discontinued is SPR206, a next-gen polymyxin ...

He says that to find new drugs to combat growing antimicrobial resistance, scientists must “look to more unusual or overlooked sources of antibiotics.” So the team grew the bacteria found in ...

Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The antibiotic, branded as Blujepa, is approved for women aged 12 years and older to treat uncomplicated UTIs, which are bacterial infections affecting the lower urinary tract in otherwise healthy ...

Researchers have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including those resistant to existing drugs. The new molecule — isolated from ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

UIC researchers working with collaborators at McMaster University in Canada determined how the new antibiotic works and why the drug evades bacterial resistance. "The holy grail in the field is to ...

Gepotidacin is the first in a new class of oral antibiotics for uUTIs in nearly 30 years. The approval was supported by results of the phase 3 EAGLE-2 and EAGLE-3 trials. The FDA approved ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...